ArticleMolecular & cellular oncology

Triple threat treatment: Exploiting the dependence receptor properties of metabotropic glutamate receptor 1 against melanoma.

Tara Gelb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.